The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HER2 alterations and prognostic implications in all subtypes of breast cancer.
 
Kaitlyn O'Keefe
No Relationships to Disclose
 
Andrew Elliott
Employment - Caris Life Sciences
 
Chad Livasy
No Relationships to Disclose
 
Meghan Steiner
No Relationships to Disclose
 
Irene Kang
Honoraria - Bristol Myer Squibb; Puma Biotechnology
Speakers' Bureau - Puma Biotechnology
 
Dave S. B. Hoon
Consulting or Advisory Role - Guardant Health
Research Funding - Bayer (Inst)
Other Relationship - Clearbridge Biomedics
 
Wolfgang Michael Korn
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
 
Phillip Walker
Employment - Caris Life Sciences
 
Milan Radovich
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Immunomedics; LifeOmic; Macrogenics; Tyme Technologies
Honoraria - Lilly
Research Funding - Boston Biomedical (Inst); Epic Sciences (Inst); Foundation Medicine (Inst); Genentech (Inst); Lilly (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Combination therapy for the treatment of TNBC with a PI3K pathway inhibitor that targets PI3KDelta and PI3KGamma (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; LifeOmic
 
Paula R Pohlmann
Leadership - Immunonet BioSciences
Stock and Other Ownership Interests - Immunonet BioSciences
Honoraria - Dava Oncology; Frontiers Media; OncLive/MJH Life Sciences
Consulting or Advisory Role - Bolt Biotherapeutics; Caris Life Sciences; HERON; Immunonet BioSciences; Juniper Pharmaceuticals; OncoPlex Diagnostics; Personalized Cancer Therapy; Pfizer; Puma Biotechnology; Sirtex Medical
Speakers' Bureau - Genentech/Roche
Research Funding - Advanced Cancer Therapeutics (Inst); Bolt Biotherapeutics (Inst); Byondis (Inst); Caris Centers of Excellence (Inst); Caris Centers of Excellence (Inst); Cascadian Therapeutics (Inst); Fabre-Kramer (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Pfizer (Inst); Pfizer (Inst); Pieris Pharmaceuticals (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Patent application; United States Patent no. 8,486,413.; United States Patent no. 8,501,417; United States Patent no. 9,023,362; United States Patent no. 9,745,377
(OPTIONAL) Uncompensated Relationships - Seagen
 
Sandra M. Swain
Consulting or Advisory Role - AstraZeneca; Athenex; Beijing Medical Award Foundation; bioTheranostics; Daiichi Sankyo; Exact Sciences; Genentech/Roche; Inivata; Lilly; Merck; Molecular Templates; Natera; Silverback Therapeutics
Research Funding - Genentech (Inst); Kailos Genetics (Inst)
Other Relationship - AstraZeneca; Roche
 
Antoinette R. Tan
Consulting or Advisory Role - Abbvie; Athenex; Celgene; Eisai; G1 Therapeutics; Genentech/Roche; immunomedics; Merck; Novartis; Pfizer; Puma Biotechnology
Research Funding - Arvinas (Inst); Daiichi Sankyo (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Pfizer (Inst)
(OPTIONAL) Uncompensated Relationships - Medscape
 
Arielle Lutterman Heeke
Honoraria - Merck
Consulting or Advisory Role - Amgen; Caris Life Sciences; Daiichi Sankyo/Astra Zeneca; Jazz Pharmaceuticals; Pfizer